ATE480246T1 - Transport von nukleinsäuresubstanzen - Google Patents

Transport von nukleinsäuresubstanzen

Info

Publication number
ATE480246T1
ATE480246T1 AT01959904T AT01959904T ATE480246T1 AT E480246 T1 ATE480246 T1 AT E480246T1 AT 01959904 T AT01959904 T AT 01959904T AT 01959904 T AT01959904 T AT 01959904T AT E480246 T1 ATE480246 T1 AT E480246T1
Authority
AT
Austria
Prior art keywords
acid
nucleic acid
administration
group
substance
Prior art date
Application number
AT01959904T
Other languages
English (en)
Inventor
Petrus Meyer
Original Assignee
Univ Northwest
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Northwest filed Critical Univ Northwest
Application granted granted Critical
Publication of ATE480246T1 publication Critical patent/ATE480246T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/60—Isolated nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Biochemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
AT01959904T 2000-07-19 2001-07-19 Transport von nukleinsäuresubstanzen ATE480246T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200003643 2000-07-19
PCT/ZA2001/000100 WO2002005849A2 (en) 2000-07-19 2001-07-19 Transportation of nucleic acid substances

Publications (1)

Publication Number Publication Date
ATE480246T1 true ATE480246T1 (de) 2010-09-15

Family

ID=25588832

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01959904T ATE480246T1 (de) 2000-07-19 2001-07-19 Transport von nukleinsäuresubstanzen

Country Status (7)

Country Link
EP (2) EP1476171B1 (de)
AT (1) ATE480246T1 (de)
AU (2) AU2001281415A1 (de)
CA (2) CA2416519C (de)
DE (1) DE60143058D1 (de)
DK (1) DK1476171T3 (de)
WO (2) WO2002005849A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2596920C (en) * 2005-01-28 2015-05-05 North-West University Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines
AU2016266011B2 (en) * 2006-02-27 2017-11-16 North-West University Plant supporting formulation, vehicle for the delivery and translocation of phytologically beneficial substances and compositions containing same
BRPI0708325A2 (pt) * 2006-02-27 2011-05-24 Univ Northwest formulação de suporte de planta, veìculo para a distribuição e deslocamento de substáncias fitologicamente benéficas, e composições contendo os mesmos
DE102006032426A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
DE102006032427A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
US20100297249A1 (en) 2007-07-05 2010-11-25 North-West University Enhancement of the efficacy of therapeutic proteins
ES2702848T3 (es) 2011-02-23 2019-03-05 Coeruleus Ltd Complejos de flumazenil, composiciones que los comprenden y usos de los mismos
CA2850964C (en) * 2011-10-05 2021-02-02 Jennifer L. Sanders Methods and compositions for treating foot or hand pain
WO2015035308A2 (en) 2013-09-06 2015-03-12 The University Of Montana Method of reducing neuronal cell death with haloalkylamines
WO2015063746A1 (en) * 2013-11-04 2015-05-07 The South African Nuclear Energy Corporation Limited Pharmaceutical composition
US20150306063A1 (en) * 2014-04-25 2015-10-29 Diane McGINNIS Composition and method for vaginal therapy
WO2018075754A1 (en) 2016-10-19 2018-04-26 Rutgers, The State University Of New Jessey System and method for determining amount of volition in a subject
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
NL2022082B1 (en) * 2018-11-28 2020-06-25 Univ Free State Transport vessels for facilitating trans-membrane transport
US12377112B2 (en) 2019-04-17 2025-08-05 Compass Pathfinder Limited Methods of treating neurocognitive disorders, chronic pain and reducing inflammation
US12240813B2 (en) 2020-05-19 2025-03-04 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use
WO2023137098A1 (en) * 2022-01-16 2023-07-20 Winsantor, Inc. Compositions and methods for improving sexual sensory disorders
WO2025155909A1 (en) * 2024-01-19 2025-07-24 Hillhurst Biopharmaceuticals, Inc. Solution of nitrous oxide for the treatment of disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2132236T3 (es) * 1992-06-08 1999-08-16 Pitmy Int Nv Composicion dermatologica conteniendo oxido nitroso.
NZ322588A (en) * 1995-11-13 1999-01-28 Pitmy Int Nv An administration medium containing nitrous oxide for use in conjunction with analgesics, anti-inflammatories and anti-pyretics to enhance their action

Also Published As

Publication number Publication date
DK1476171T3 (da) 2011-01-10
CA2416519A1 (en) 2002-01-24
CA2416650C (en) 2010-09-21
WO2002005849A2 (en) 2002-01-24
AU2001281415A1 (en) 2002-01-30
CA2416650A1 (en) 2002-01-24
CA2416519C (en) 2011-09-20
WO2002005849A3 (en) 2002-07-25
AU2001281416A1 (en) 2002-01-30
EP1476195A2 (de) 2004-11-17
DE60143058D1 (de) 2010-10-21
EP1476195B1 (de) 2015-05-13
WO2002005851A3 (en) 2002-08-08
WO2002005851A2 (en) 2002-01-24
EP1476171A2 (de) 2004-11-17
EP1476171B1 (de) 2010-09-08
WO2002005851A8 (en) 2002-12-27

Similar Documents

Publication Publication Date Title
DE60143058D1 (de) Transport von nukleinsäuresubstanzen
NZ608755A (en) Plant support formulation, vehicle for the delivery and translocation of phytologically beneficial substances and compositions containing same
ES2567569T3 (es) Preparación de aceite microbiano que contiene ácidos grasos poliinsaturados
ATE165212T1 (de) Docosahexaensäure, verfahren zu ihrer herstellung und sie enthaltende verbindungen
DK0956013T3 (da) Farmaceutisk præparat indeholdende eicosapentaensyre og/eller stearidonsyre
AR006425A1 (es) Aceite microbiano, procedimiento para obtenerlo, composiciones alimenticias, cosmeticas o suplementos nutricionales que lo contienen yacidos poliinsaturados extraidos, recuperados o aislados de dicho aceite
PL329926A1 (en) Method of obtaining a paraffin-based product, odorizing agent concentrate and paraffin-based product as such
KR930000113A (ko) 약학 조성물
ATE192647T1 (de) Medikamente auf der basis von docosahexaensäure, als plättchenaggregationshemmer und gegen cerebralen mangel an fettsäuren, und verfahren zur herstellung.
ES2168271T3 (es) Composiciones farmaceuticas que contienen ciclosporinas.
DE60132508D1 (de) Zusammensetzungen enthaltend Phytosterol- und Policosanolester von Fettsäuren zur Herabsetzung des Cholesterol- und Triglyceridspiegels
ATE178883T1 (de) Synthetische ester aus alkoholen und fettsäuregemischen aus ölsäurereichen, stearinsäurearmen pflanzenölen
EP2175031A3 (de) Verfahren zur Herstellung hoch ungesättigter Fettsäuren und Fette mit hoch ungesättigten Fettsäuren
WO2002005850A3 (en) Enhancement of the action of anti-infective agents
Alakhras et al. Fatty acid lithium salts from Cunninghamella echinulata have cytotoxic and genotoxic effects on HL‐60 human leukemia cells
PT1396533E (pt) Processo de preparação de um óleo contendo um ou mais ácidos gordos polinsaturados de cadeia longa provenientes de biomassa e alimento, composição nutricional, cosmética ou farmacêutica que o contém
NZ247946A (en) Method for stabilising polyunsaturates by using ascorbic acid (or ester thereof) and a phosphorylated mono- or di- fatty acyl glyceride
JPWO2020050303A1 (ja) リパーゼ加水分解反応を用いる高度不飽和脂肪酸含有グリセリドの製造方法
AU743992B2 (en) Process for producing omega-9 highly unsaturated fatty acid and lipid containing the same
ATE531389T1 (de) Lipid- und distickstoffoxidverbindung als hilfsmittel zur erhöhung der impfstoffeffizienz
Feltes et al. Incorporation of medium chain fatty acids into fish oil triglycerides by chemical and enzymatic interesterification
Karmee The synthesis, properties, and applications of ascorbyl esters
JPH01199588A (ja) 糸状菌による高度不飽和脂肪酸の製造法
JP2545480B2 (ja) 機能性食品素材
Park et al. Concentration of docosahexsaenoic acid from tuna oil by a combination of solvent crystallization and lipase‐catalyzed ethanolysis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1476171

Country of ref document: EP